ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Analysis of the pathogens and clinical characteristics of pediatric necrotizing pneumonia patients in a tertiary grade a hospital from 2019 to 2025: a retrospective study design.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the pathogens and clinical characteristics of necrotizing pneumonia (NP) in our hospital from January 2019 to June 2025.
methodsWe retrospectively analyzed the clinical data of children with NP. Patients were divided into a single- bronchoalveolar lavage (BAL) group and a multiple-BAL group. Pathogens and clinical characteristics were compared between the two groups.
resultsThis study included 365 patients with NP, 193 of whom were males. The incidence of NP significantly increased in 2023-2024. The pathogen identification rate was 98.36%, with Mycoplasma pneumoniae (MP) being the most commonly pathogen (91.00%). There were 138 cases of mixed infection and 227 cases of single infection. The 335 cases underwent BAL, with 139 cases assigned to the single-BAL group. Follow-up within 6 months after discharge was conducted for 238 patients, and the majority exhibited a favorable prognosis. No statistical differences were observed between the two groups regarding gender, age, time from onset to diagnosis, or duration of fever. However, a significant difference was noted in the length of hospital stay (P < 0.05). The infection rate of MP in the single-BAL group was lower than that in the multiple-BAL group (P < 0.05).
conclusionThe incidence of NP significantly increased in 2023-2024, with MP as the predominant pathogen. Children with NP present with severe clinical symptoms, a prolonged disease course, and significantly elevated inflammatory markers. Most NP patients have a favorable prognosis. Patients requiring multiple BAL procedures demonstrate a higher MP infection rate.
Indexed as
Identifiers
41240235What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.